Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1999 Sep;43(9):2131-7.
doi: 10.1128/AAC.43.9.2131.

Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field

Affiliations
Comparative Study

Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field

E Giraud et al. Antimicrob Agents Chemother. 1999 Sep.

Abstract

The occurrence of mutations in the genes coding for gyrase (gyrA and gyrB) and topoisomerase IV (parE and parC) of Salmonella typhimurium experimental mutants selected in vitro and in vivo and of 138 nalidixic acid-resistant Salmonella field isolates was investigated. The sequencing of the quinolone resistance-determining region of these genes in highly fluoroquinolone-resistant mutants (MICs of 4 to 16 microg/ml) revealed the presence of gyrA mutations at codons corresponding to Gly-81 or Ser-83, some of which were associated with a mutation at Asp-87. No mutations were found in the gyrB, parC, and parE genes. An assay combining allele-specific PCR and restriction fragment length polymorphism was developed to rapidly screen mutations at codons 81, 83, and 87 of gyrA. The MICs of ciprofloxacin for the field isolates reached only 2 microg/ml, versus 16 microg/ml for some in vitro-selected mutants. The field isolates, like the mutants selected in vivo, had only a single gyrA mutation at codon 83 or 87. Single gyrA mutations were also found in highly resistant in vitro-selected mutants (MIC of ciprofloxacin, 8 microg/ml), which indicates that mechanisms other than the unique modification of the intracellular targets could participate in fluoroquinolone resistance in Salmonella spp. A comparison of experimental mutants selected in vitro, field strains, and mutants selected in vivo suggests that highly fluoroquinolone-resistant strains are counterselected in field conditions in the absence of selective pressure.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Schematic diagram of AS-PCR-RFLP assay of a strain with no mutation at codon 81, 83, or 87.
FIG. 2
FIG. 2
AS-PCR-RFLP patterns of six representative strains before (A) and after (B) HinfI digestion. See Table 2 for theoretical fragment sizes according to the gyrA sequence. Lane M, molecular weight marker.

References

    1. Barnass S, Franklin J, Tabaqchali S. The successful treatment of multiresistant non-enteric salmonellosis with seven day oral ciprofloxacin. J Antimicrob Chemother. 1990;25:299–300. - PubMed
    1. Belland R J, Morrison S G, Ison C, Huang W M. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol. 1994;14:371–380. - PubMed
    1. Björkman J, Hughes D, Andersson D I. Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci USA. 1998;95:3949–3953. - PMC - PubMed
    1. Breines D M, Ouabdesselam S, Ng E Y, Tankovic J, Shah S, Soussy C J, Hooper D C. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob Agents Chemother. 1997;41:175–179. - PMC - PubMed
    1. Brisabois A, Cazin I, Breuil J, Collatz E. Surveillance of antibiotic resistance in Salmonella. Eurosurveillance. 1997;2:19–20. - PubMed

Publication types

MeSH terms

LinkOut - more resources